Selvedge Venture
Robert Thong is a distinguished leader in the fields of precision medicine and venture development, currently serving as Co-Founder and Chief Executive Officer of Multiomic Health, which focuses on innovative therapeutics for metabolic syndrome. Additionally, Robert Thong is a Venture Development Partner at Selvedge Venture, and holds positions as Non Executive Director at Oxford Medical Products and Investor/Advisor at Mesh Bio. With extensive academic engagement, Robert Thong teaches at the University of Cambridge and UCL, specializing in business models and R&D alliances. Previous roles include advising startups through SciTechStrategy and leadership positions at Repositive and Dog Stories London. Robert Thong's educational background includes advanced degrees from MIT, Imperial College London, and the Institute of Actuaries UK.
This person is not in any teams
Selvedge Venture
Selvedge Venture is a venture capital firm investing for impact in age-related medical conditions. We invest in platform technologies and interventions that are expected to transform patient outcomes in age-related medical conditions such as Metabolic Syndrome (Cardiovascular Disease, Diabetes, Fatty Liver Disease and Obesity), Oncology and Neurodegeneration. Selvedge Venture was founded by experienced professionals from the venture capital, healthcare, life science and pharmaceutical industries. We are backed by an investor base of family offices and high net worth individuals.